Nội dung được dịch bởi AI, chỉ mang tính chất tham khảo
Di căn hạch bạch huyết của sarcoma mô mềm: các yếu tố rủi ro, kết quả hình ảnh và ý nghĩa
Tóm tắt
Sarcoma mô mềm (STS) là loại ác tính có nguồn gốc từ mô liên kết, và di căn hạch bạch huyết vùng (RLNM), mặc dù không phổ biến, vẫn là một khía cạnh quan trọng trong việc dự đoán và điều trị. Nhiều yếu tố rủi ro, đặc biệt là kiểu mô học, ảnh hưởng đến khả năng tổn thương hạch bạch huyết, mà có thể được xác định qua các đặc điểm hình ảnh như kích thước và hình thái của hạch. Hiện tại, việc giám sát và quản lý khác nhau giữa các cơ sở y tế, do vẫn chưa có hướng dẫn cụ thể từ các tổ chức y tế. Các chiến lược đánh giá tình trạng hạch thường gặp bao gồm kiểm tra lâm sàng, siêu âm, CT, MRI, sinh thiết hạch bạch huyết trọng điểm (SLNB) và cắt bỏ hạch bạch huyết triệt để. Bài viết này tóm tắt dữ liệu liên quan đến các yếu tố rủi ro của RLNM, các đặc điểm hình ảnh, và bất kỳ dữ liệu nào có sẵn liên quan đến khuyến nghị giám sát.
Từ khóa
#sarcoma mô mềm #di căn hạch bạch huyết #yếu tố rủi ro #hình ảnh y học #giám sátTài liệu tham khảo
Gandhi J, Mehta S, Patel T, Gami A, Shah M, Jetly D. Metastasis of soft tissue sarcomas in lymph node: a cytomorphological study. Diagn Cytopathol. 2017;45(9):784–8.
Greenberg DD. CORR insights(R): synovial sarcoma is not associated with a higher risk of lymph node metastasis compared with other soft tissue sarcomas. Clin Orthop Relat Res. 2018;476(3):599–600.
Fong Y, Coit DG, Woodruff JM, Brennan MF. Lymph node metastasis from soft tissue sarcoma in adults. Analysis of data from a prospective database of 1772 sarcoma patients. Ann Surg. 1993;217(1):72–7.
Jacobs AJ, Morris CD, Levin AS. Synovial sarcoma is not associated with a higher risk of lymph node metastasis compared with other soft tissue sarcomas. Clin Orthop Relat Res. 2018;476(3):589–98.
Weingrad DN, Rosenberg SA. Early lymphatic spread of osteogenic and soft-tissue sarcomas. Surgery. 1978;84(2):231–40.
Loya AC, Prayaga AK, Arora A, Sundaram C, Rao IS, Uppin SG, et al. Lymph node metastasis of soft tissue tumors: a cytomorphologic study. Acta Cytol. 2007;51(2):153–60.
Miccio JA, et al. Predictors of lymph node involvement by soft tissue sarcoma: an analysis of the National Cancer Database (NCDB). Int J Radiat Oncol Biol Phys. 2018;102(Issue 3):e335.
Wang H, Miao R, Jacobson A, Boyd G, Goldberg S, Mitra D, et al. Nodal involvement and survival in synovial, clear cell, angio, rhabdo, and epithelioid sarcoma. J Clin Oncol. 2018;36(15_suppl):11567.
Keung EZ, Chiang YJ, Voss RK, Cormier JN, Torres KE, Hunt KK, et al. Defining the incidence and clinical significance of lymph node metastasis in soft tissue sarcoma. Eur J Surg Oncol. 2018;44(1):170–7.
Ashamalla M, Guirguis A, Mokhtar BE, Ashamalla H. Clinical presentation and patterns of care in SCARE soft tissue sarcoma. Int J Radiat Oncol Biol Phys. 2017;99(2):E749.
Mazeron J-J, Suit HD. Lymph nodes as sites of metastases from sarcomas of soft tissue. Cancer. 1987;60(8):1800–8.
Ruka W, Emrich LJ, Driscoll DL, Karakousis CP. Prognostic significance of lymph node metastasis and bone, major vessel, or nerve involvement in adults with high-grade soft tissue sarcomas. Cancer. 1988;62(5):999–1006.
Gaakeer HA, et al. Regional lymph node metastases in patients with soft tissue sarcomas of the extremities, what are the therapeutic consequences? Eur J Surg Oncol. 1988;14(2):151–6.
Riad S, Griffin AM, Liberman B, Blackstein ME, Catton CN, Kandel RA, et al. Lymph node metastasis in soft tissue sarcoma in an extremity. Clin Orthop Relat Res. 2004;426:129–34.
Behranwala KA, A’Hern R, Omar A-M, Thomas JM. Prognosis of lymph node metastasis in soft tissue sarcoma. Ann Surg Oncol. 2004;11(7):714–9.
Daigeler A, Kuhnen C, Moritz R, Stricker I, Goertz O, Tilkorn D, et al. Lymph node metastases in soft tissue sarcomas—a single center analysis of 1,597 patients. Langenbeck's Arch Surg. 2009;394(2):321–9.
Sherman KL, Kinnier CV, Farina DA, Wayne JD, Laskin WB, Agulnik M, et al. Examination of national lymph node evaluation practices for adult extremity soft tissue sarcoma. J Surg Oncol. 2014;110(6):682–8.
Crettenand F, Martin D, Cherix S, Demartines N, Matter M. Occurrence and prognosis of lymph node metastases in patients selected for isolated limb perfusion with soft tissue sarcoma. J Cancer. 2018;9(18):3311–5.
Nelen SD, Vogelaar FJ, Gilissen F, Van der Linden JC, Bosscha K. Lymph node metastasis after a soft tissue sarcoma of the leg: a case report and a review of the literature. Case reports in surgery. 2013;2013:930361.
Maduekwe UN, Hornicek FJ, Springfield DS, Raskin KA, Harmon DC, Choy E, et al. Role of sentinel lymph node biopsy in the staging of synovial, epithelioid, and clear cell sarcomas. Ann Surg Oncol. 2009;16(5):1356.
Coindre J-M. Grading of soft tissue sarcomas: review and update. Arch Pathol Lab Med. 2006;130(10):1448–53.
Collin C, Godbold J, Hajdu S, Brennan M. Localized extremity soft tissue sarcoma: an analysis of factors affecting survival. J Clin Oncol Off J Am Soc Clin Oncol. 1987;5(4):601–12.
Andreou D, Boldt H, Werner M, Hamann C, Pink D, Tunn PU. Sentinel node biopsy in soft tissue sarcoma subtypes with a high propensity for regional lymphatic spread--results of a large prospective trial. Ann Oncol. 2013;24(5):1400–5.
Ferguson PC, Deheshi BM, Chung P, Catton CN, O'Sullivan B, Gupta A, et al. Soft tissue sarcoma presenting with metastatic disease. Cancer. 2011;117(2):372–9.
Vezeridis MP, Moore R, Karakousis CP. Metastatic patterns in soft-tissue sarcomas. JAMA Surg. 1983;118(8):915–8.
Nakamura T, Matsumine A, Matsubara T, Asamuma K, Niimi R, Uchida A, et al. Retrospective analysis of metastatic sarcoma patients. Oncol Lett. 2011;2(2):315–8.
Roberts CC, Kransdorf MJ, Beaman FD, Adler RS, Amini B, Appel M, et al. ACR appropriateness criteria follow-up of malignant or aggressive musculoskeletal tumors. J Am Coll Radiol: JACR. 2016;13(4):389–400.
Robinson E, Bleakney RR, Ferguson PC, O’Sullivan B. Multidisciplinary management of soft-tissue sarcoma. RadioGraphics. 2008;28(7):2069–86.
Kassem TW, Abdelaziz O, Emad-Eldin S. Diagnostic value of 18F-FDG-PET/CT for the follow-up and restaging of soft tissue sarcomas in adults. Diagnostic and Interventional Imaging. 2017;98(10):693–8.
Tateishi U, Yamaguchi U, Seki K, Terauchi T, Arai Y, Kim EE. Bone and soft-tissue sarcoma: preoperative staging with fluorine 18 fluorodeoxyglucose PET/CT and conventional imaging. Radiology. 2007;245(3):839–47.
Partovi S, Kohan AA, Zipp L, Faulhaber P, Kosmas C, Ros PR, et al. Hybrid PET/MR imaging in two sarcoma patients - clinical benefits and implications for future trials. Int J Clin Exp Med. 2014;7(3):640–8.
Tateishi U, Yamaguchi U, Maeda T, Seki K, Terauchi T, Kawai A, et al. Staging performance of carbon-11 choline positron emission tomography/computed tomography in patients with bone and soft tissue sarcoma: comparison with conventional imaging. Cancer Sci. 2006;97(10):1125–8.
Ganeshalingam S, Koh DM. Nodal staging. Cancer Imaging. 2009;9(1):104–11.
Torabi M, Aquino SL, Harisinghani MG. Current concepts in lymph node imaging. J Nucl Med. 2004;45(9):1509–18.
Shetty SK, Harisinghani MG. Magnetic resonance techniques in lymph node imaging. Appl Radiol. 2004. https://appliedradiology.com/articles/magnetic-resonance-techniques-in-lymph-node-imaging. Accessed 20 Aug 2019.
Wright S, Armeson K, Hill EG, Streck C, Leddy L, Cole D, et al. The role of sentinel lymph node biopsy in select sarcoma patients: a meta-analysis. Am J Surg. 2012;204(4):428–33.
Johannesmeyer D, Smith V, Cole DJ, Esnaola NF, Camp ER. The impact of lymph node disease in extremity soft-tissue sarcomas: a population-based analysis. Am J Surg. 2013;206(3):289–95.
Rutkowski P, Lugowska I. Follow-up in soft tissue sarcomas. Memo. 2014;7(2):92–6.
Terwisscha van Scheltinga CEJ, Spronk P, van Rosmalen J, Wijnen MHWA, Heij HA, van Baren R, et al. Diagnosis and treatment of lymph node metastases in pediatric rhabdomyosarcoma in the Netherlands: a retrospective analysis. J Pediatr Surg. 2014;49(3):416–9.
Kim JR, Yoon HM, Koh K-N, Jung AY, Cho YA, Lee JS. Rhabdomyosarcoma in children and adolescents: patterns and risk factors of distant metastasis. Am J Roentgenol. 2017;209(2):409–16.
Blazer DG, Sabel MS, Sondak VK. Is there a role for sentinel lymph node biopsy in the management of sarcoma? Surg Oncol. 2003;12(3):201–6.
